Prophylaxe der venösen Thrombose

  • J. Harenberg
  • S. Haas
  • K. H. Breddin

Zusammenfassung

Thromboembolische Ereignisse stellen eine schwerwiegende Komplikation in der chirurgischen und inneren Medizin dar. Die tödliche Lungenembolie entsteht bei etwa 3% der Patienten nach Hüftgelenkersatz, bei 0,1–6% der Patienten in der Abdominalchirurgie bis hin zu 8% bei ausgedehnten Amputationen der unteren Extremität und bei 1–5% der Patienten mit internistischen Erkrankungen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abernethy EE, Hartsuck J (1974) Postoperative pulmonary embolism: A prospective study utilizing low-dose heparin. Am J Surg 128:739–742PubMedCrossRefGoogle Scholar
  2. Antiplatelet Trialists’ Collaboration Group (1994) Collaborative overview of randomized trials of antiplatelet therapy III: Reduction of venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J 308:235–246CrossRefGoogle Scholar
  3. Ballard RM, Bradley-Watson PJ, Johnstone FD et al. (1973) Low doses of subcutaneous heparin in the prevention of deep vein thrombosis after gynecological surgery. J Obstet Gynecol Br Commonw 80:469–475CrossRefGoogle Scholar
  4. Bergmann JF, Neuhardt E (1996) A multicenter randomized double-blind study of Enoxaparin compared with unfrac-tionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. Thromb Haemost 76:529–534PubMedGoogle Scholar
  5. Bergqvist D (1997) New approaches to prevention of deep-vein thrombosis. Thromb Haemost 78:684–688PubMedGoogle Scholar
  6. Bergqvist D, Burmark US, Frisell J et al. (1986) Low molecular weight heparin once daily compared with conventional low dose heparin twice daily: A prospective double-blind multicentre trial on prevention of postoperative thrombosis. Br J Surg 73:204–208PubMedCrossRefGoogle Scholar
  7. Bergqvist D, Mätzsch T, Burmark US et al. (1988) Low molecular weight heparin given the evening before surgery compared with conventional low dose heparin in prevention of thrombosis. Br J Surg 75:888–891PubMedCrossRefGoogle Scholar
  8. Bergqvist D, Kettunen K, Fredin H et al. (1991) Thromboprophylaxis in hip fracture patients — A prospective randomized comparative study between ORG 10172 and dextran. Surgery 109:617–624PubMedGoogle Scholar
  9. Bergqvist D, Benoni G, Bjorgell O et al. (1996) Low molecular weight heparin (Enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 335:696–700PubMedCrossRefGoogle Scholar
  10. Borgstrom S, Greitz T, Vander Linden W et al. (1965) Anticoagulant prophylaxis of venous thrombosis in patients with fractured neck of the femur: A controlled clinical trial using venous phlebography. Acta Chir Scand 129:500–508Google Scholar
  11. Caen JO (1988) A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. Thromb Haemost 59:216–220PubMedGoogle Scholar
  12. Clagett GP, Anderson FA, Heit J et al. (1995) Prevention of venous thromboembolism. Chest 108(Suppl):313S–334SGoogle Scholar
  13. Cook DJ, Guyatt GH, Laupacis A et al. (1995) Clinical recommendations using levels of evidence for antithrombotic agents. Chest 108:227S–230SPubMedCrossRefGoogle Scholar
  14. Covey TH, Sherman L, Baue E (1975) Low dose heparin in postoperative patients. Arch Surg 110:1021–1028PubMedCrossRefGoogle Scholar
  15. Czechanowski B, Heinrich F (1981) Prophylaxe venöser Thrombosen bei frischem ischämischen zerebrovaskulä-ren Insult. Doppelblindstudie mit Heparin-Dihydergot. Dtsch Med Wochenschr 106:1254–1260PubMedCrossRefGoogle Scholar
  16. Dahan R, Houlbert D, Caulin C et al. (1986) Prevention of deep vein thrombosis in elderly medical patients by a low molecular weight heparin: A randomized double-blind trial. Haemostasis 16:159–168PubMedGoogle Scholar
  17. Dahl OE, Andreassen G, Aspelin T et al. (1997) Prolonged thromboprophylaxis after hip replacement surgery — results of a double-blind prospective, randomized, placebo-controlled study with Dalteparin (Fragmin). Thromb Haemost 77:26–31PubMedGoogle Scholar
  18. Danish Enoxaparin Study Group (1991) Low-molecular-weight heparin (Enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. Arch Intern Med 151:1621–1626CrossRefGoogle Scholar
  19. Dechavanne M, Saudin F, Viala JJ et al. (1974) Prevention des thromboses veineuses: Succes de l’ heparine a fortes doses lors des Coxarthrose. Nouv Presse Med 3:1317–1319PubMedGoogle Scholar
  20. Dechavanne M, Ville D, Berruyer M et al. (1989) Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery. Haemostasis 19:5–12PubMedGoogle Scholar
  21. Emerson PA, Marks P (1977) Preventing thromboembolism after myocardial infarction: effect of low-dose heparin on smoking. Brit Med J 1:18–20PubMedCrossRefGoogle Scholar
  22. Encke A, Breddin KH (1988) Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. Br J Surg 75:1058–1063CrossRefGoogle Scholar
  23. Eriksson BI, Kalebo P, Anthmyr BA et al. (1991) Prevention of deep vein thrombosis and pulmonary embolism after total hip replacement. J Bone Joint Surg 73A:484–493Google Scholar
  24. Eriksson BI, Ekman S, Kalebo P et al. (1996) Prevention of deep vein thrombin after total hip replacement: direct thrombosis inhibition with recombinant hirudin, CGP 39393. Lancet 347:635–639PubMedCrossRefGoogle Scholar
  25. Eriksson BI, Wille-Jorgensen P, Kalebo P et al. (1997) A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 337:1329–1335PubMedCrossRefGoogle Scholar
  26. Eskeland G, Solheim K, Skorten F (1966) Anticoagulant prophylaxis, thromboembolism and mortality in elderly patients with hip fractures: A controlled clinical trial. Acta Chir Scand 131:16–24PubMedGoogle Scholar
  27. Estoppey D, Hochreiter J, Breyer HG et al. (1989) ORG 10172 (Lomoparin) versus heparin-DHE in prevention of thromboembolism in total hip replacement — A multicentre trial. Thromb Haemost 62:356–362Google Scholar
  28. Francis CW, Meyer D, Roberts E et al. (1983) Two-step warfarin therapy: Prevention of postoperative venous thrombosis without excessive bleeding. JAMA 249:374–378PubMedCrossRefGoogle Scholar
  29. Freeark KA, Boswick J, Fardin R (1967) Posttraumatic venous thrombosis. Arch Surg 95:567–575PubMedCrossRefGoogle Scholar
  30. Fricker JP, Vergnes Y, Schach R et al. (1988) Low dose heparin versus low molecular weight heparin Kabi 2165 in the prophylaxis of thromboembolic complications of abdominal oncological surgery. Eur J Clin Invest 18:561–572PubMedCrossRefGoogle Scholar
  31. Gallus AS, Hirsh J, Tuttle RJ et al. (1973) Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med 288:545–551PubMedCrossRefGoogle Scholar
  32. Gallus AS, Hirsh J, O’ Brien SE et al. (1975) Prevention of venous thrombosis with small subcutaneous doses of heparin. JAMA 235:980–989Google Scholar
  33. Geerts WH, Code KJ, Jay RM et al. (1994) A prospective study of venous thromboembolism after major trauma. N Engl J Med 331:1601–1606PubMedCrossRefGoogle Scholar
  34. Geerts WH, Jay RM, Code KJ et al. (1996) A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 335:701–717PubMedCrossRefGoogle Scholar
  35. GHAT Group (1992) Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. Arch Orthop Trauma Surg 111:110–120CrossRefGoogle Scholar
  36. Gibbert FB, Gould SR, Marks P (1976) Incidence of deep vein thrombosis and leg oedema in patients with stroke. J Neurol Neurosurg Psychiatr 39:1222–1225CrossRefGoogle Scholar
  37. Gordon-Smith IC, Le Queste LP, Grundy DJ, Newcombe JF (1972) Controlled trial of two regimens of subcutaneous heparin in prevention of postoperative deep-vein thrombosis. Lancet 1:1133–1135PubMedCrossRefGoogle Scholar
  38. Green D, Lee MY, Lim AC et al. (1990) Prevention of thromboembolism after spinal cord injury using low molecular weight heparin. Ann Intern Med 113:571–574PubMedCrossRefGoogle Scholar
  39. Groote Schuur Hospital Thromboembolus Study Group (1979) Failure of low-dose heparin to prevent significant thromboembolic complications in high-risk surgical patients: interim report of prospective trial. Br Med J 1:1447–1450CrossRefGoogle Scholar
  40. Gruber UF, Duckert F, Fridrich R et al. (1977) Prevention of postoperative thromboembolism by dextran 40, low doses of heparin, or xantional nicotinate. Lancet 1:207–214PubMedCrossRefGoogle Scholar
  41. Haas S (1996) Risikoabschätzung thromboembolischer Komplikationen bei chirurgischen Erkrankungen und Verletzungen. Akt Chir 31:269–274Google Scholar
  42. Hamilton HW, Crawford JS, Gardiner JH, Wiley AM (1970) Venous thrombosis in patients with fracture of the upper end of the femur. J Bone Joint Surg 52B:268–274Google Scholar
  43. Hampson WGJ, Harris PC, Lucas HK et al. (1974) Failure of low-dose heparin to prevent deep-vein thrombosis after hip replacement arthroplasty. Lancet 11:795–789CrossRefGoogle Scholar
  44. Handley AJ (1972) Low dose heparin after myocardial infarction. Lancet 11:623–624CrossRefGoogle Scholar
  45. Harenberg J, Schmitz-Huebner U (1997) Therapie der Beinvenenthrombose mit niedermolekularen Heparinen. Dt Ä rztebl 94:A-2257, B-1837, C-1703Google Scholar
  46. Harenberg J, Kallenbach B, Martin U et al. (1990) Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients. Thromb Res 59:639–650PubMedCrossRefGoogle Scholar
  47. Harenberg J, Roebruck P, Heene DL (1996) Subcutaneous low-molecular-weight heparin versus standard heparin for prevention of thromboembolism in medical in-patients. Haemostasis 26:127–139PubMedGoogle Scholar
  48. Hartle P, Brucke P, Dienstl E, Vinazzer H (1990) Prophylaxis of thromboembolism in general surgery: Comparison between standard heparin and Fragmin. Thromb Res 57:577–584CrossRefGoogle Scholar
  49. Heit J, Kessler C, Mammen E et al. for the RD Heparin Study Group (1991) Efficacy of RD heparin (a LMWH) and warfarin for prevention of deep-vein thrombosis after hip or knee replacement. Blood 72:831–840Google Scholar
  50. Hume M, Kuriakose T, Xavier ZI, Turner RH (1973) 125I-fibrinogen and the prevention of venous thrombosis. Arch Surg 107:803–812PubMedCrossRefGoogle Scholar
  51. International Multicentre Trial (1975) Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Lancet 11:45–51Google Scholar
  52. Kakkar VV, Murray WJG (1985) Efficacy and safety of low molecular weight heparin (CY216) in preventing postoperative venous thromboembolism. Br J Surg 72:786–791PubMedCrossRefGoogle Scholar
  53. Kakkar VV, Spindler J, Flute PT et al. (1972) Efficacy of low-doses of heparin in prevention of deep-vein thrombosis after major surgery: A double-blind randomized trial. Lancet 11:101–106CrossRefGoogle Scholar
  54. Keser C, Groh J, Schramm W, Peter K (1997) Thromboembolieprophylaxe mit Heparinen: Gefahr bei rückenmarknaher Anästhesie? Heparin 11:1–6Google Scholar
  55. Koppenhagen K (1997) Empfehlungen zur stationären und ambulanten Thromboembolie-Prophylaxe in der Chirurgie. Expertengespräch zur Thromboembolie-Prophylaxe. Mitteilungen der Deutschen Gesellschaft für Chirurgie 5, DemeterGoogle Scholar
  56. Kudsk KA, Fabian TC, Baum S et al. (1989) Silent deep vein thrombosis in immobilized multiple trauma patients. Am J Surg 158:515–519PubMedCrossRefGoogle Scholar
  57. Lahnborg G, Friman L, Bergstrom K, Lagergren H (1974) Effect of low-dose heparin on incidence of postoperative pulmonary embolism detected by photoscanning. Lancet 1:329–331PubMedCrossRefGoogle Scholar
  58. Lassen M, Borris L (1995) Prolonged thromboprophylaxis with low molecular weight heparin (Fragmin) after elective total hip arthroplasty -’ a placebo controlled study. Thromb Haemost 73:1104Google Scholar
  59. Lechler E, Schramm W, Flosbach CW (1996) The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (Enoxaparin). The Prime Study Group. Haemostasis 26 (Suppl 2):49–56PubMedGoogle Scholar
  60. Leizorovicz A, Picolet H, Peyrieux JC, Boissel JP (1991) Prevention of perioperative deep vein thrombosis in general surgery: A multicentre double-blind study comparing two doses of logiparin and standard heparin. Br J Surg 78:412–416CrossRefGoogle Scholar
  61. Leizorovicz A, Haugh MC, Chapuis FR et al. (1992) Low molecular weight heparin in the prevention of perioperative thrombosis. Br Med 305:913–920CrossRefGoogle Scholar
  62. Levine MN, Hirsh J, Gent et al. (1991) Prevention of deep vein thrombosis after elective hip surgery: A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 114:545–551PubMedCrossRefGoogle Scholar
  63. Leyvraz PF, Bachmann F, Hoek J et al. (1991) Prevention of deep vein thrombosis after hip replacement: Randomized comparison between unfractionated heparin and low molecular weight heparin. Br Med J 303:543–548CrossRefGoogle Scholar
  64. Mannucci PM, Citterio LA, Penajotopoulos N (1976) Low-dose heparin and deep vein thrombosis after total hip replacement. Thromb Haemost 36:157–164PubMedGoogle Scholar
  65. Mätzsch T, Bergqvist D, Fredin H et al. (1991) Comparison of the thromboprophylactic effect of low molecular weight heparin versus dextran in total hip replacement. Thromb Haemorrh Disorders 3:25–29Google Scholar
  66. McCarthy ST, Robertsson D, Turner JJ, Hawkey CJ (1977) Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet 11:800–801CrossRefGoogle Scholar
  67. Molnar L, Demeter I, Vamosi B, Csornai M (1981) Phlebothrombose der unteren Extremitäten bei Kranken mit Hemiplegie nach zerebralem Insult. Folia Angiol 29:16–19Google Scholar
  68. Morris GK, Mitchell JR (1975) Warfarin sodium in the prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur. Lancet 11:869–871Google Scholar
  69. Morris GK, Henry APJ, Preston BJ (1974) Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement. Lancet 11:797–801CrossRefGoogle Scholar
  70. Moskovitz PA, Ellenberg SS, Feffer HL et al. (1978) Low dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures. J Bone Joint Surg 60:1065–1070PubMedGoogle Scholar
  71. Nicolaides AN, Dupont PA, Desais S et al. (1972) Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet 11:890–893CrossRefGoogle Scholar
  72. Nurmohamed MT, Rosendaal FR, Büller HR et al. (1991) Low molecular weight heparin versus Standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 340:152–155CrossRefGoogle Scholar
  73. Nylander G, Semb H (1972) Veins of the lower limb after tibial fractures. Surg Gynecol Obstet 134:974–977PubMedGoogle Scholar
  74. Pezzuoli G, Neri Serneri GG, Settembrini P et al. (STEP-Study Group) (1989) Prophylaxis of fatal pulmonary embolism in general surgery using low molecular weight heparin CY 216: A multicentre double-blind randomized controlled clinical trial versus placebo. Int Surg 74:205–214PubMedGoogle Scholar
  75. Pinto DJ (1970) Controlled trial of an anticoagulant (warfarin sodium) in the prevention of venous thrombosis following hip surgery. Br J Surg 57:349–354PubMedCrossRefGoogle Scholar
  76. Planes A, Vochelle N, Mazas F et al. (1988) Prevention of postoperative venous thrombosis: A randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 60:407–410PubMedGoogle Scholar
  77. Planes A, Vochelle N, Darmon JY et al. (1996) Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomized comparison of Enoxaparin versus placebo. Lancet 348:224–228PubMedCrossRefGoogle Scholar
  78. Prasad BK, Banerjee AK, Howard H (1982) Incidence of deep vein thrombosis and effect of pneumatic compression of the calf in elderly hemiplegics. Age Ageing 11:42–44PubMedCrossRefGoogle Scholar
  79. Prins MH, Gelsema R, Sing AK, van Heerala LR, Ottolander GJH (1989) Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients. Haemostasis 19:245–250PubMedGoogle Scholar
  80. Rem J, Duckert F, Fridrich R, Gruber UF (1975) Subkutane kleine Heparindosen zur Thromboseprophylaxe in der allgemeinen Chirurgie und Urologie. Schweiz Med Wo-chenschr 105:827–832Google Scholar
  81. Roise OM, Nurmohamed M, Reijnders P et al. (1993) A multicentre, randomised, assessor-blind, pilot study comparing the efficacy in the prophylaxis of DVT and the safety of Orgaran® (ORG 10172), Fragmin®, Clexane®/Love-nox® in patients undergoing surgery for a fractured hip. Thromb Haemost 69:273 (Abstract)Google Scholar
  82. Rosenberg IL, Evans M, Pollock AV (1975) Prophylaxis of postoperative leg vein thrombosis by low-dose subcutaneous heparin or preoperative calf muscle stimulation. A controlled clinical trial. Br Med J 1:649–651PubMedCrossRefGoogle Scholar
  83. Samama M, Bernard P, Bonnardot JP et al. (1988) Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis. Br J Surg 75:128–134PubMedCrossRefGoogle Scholar
  84. Scottish Study (1974) A multi-unit controlled trial: heparin versus dextran in the prevention of deep-vein thrombosis. Lancet 11:118–124Google Scholar
  85. Sevitt S, Gallagher NG (1959) Prevention of venous thrombosis and pulmonary embolism in injured patients: a trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur. Lancet 11:981–989CrossRefGoogle Scholar
  86. Sevitt S, Gallagher N (1961) Venous thrombosis and pulmonary embolism: a clinicopathologic study in injured and burned patients. Br J Surg 45:475–489CrossRefGoogle Scholar
  87. Sharnoff JG (1966) Results in the prophylaxis of postoperative thromboembolism. Surg Gynecol Obstet 123:303–307PubMedGoogle Scholar
  88. Spiro TE, Enoxaparin Clinical Trials Group (1991) A randomized trial of enoxaparin administered postoperatively for the prevention of deep vein thrombosis following elective hip replacement. Thromb Haemost 65:824 (Abstract)Google Scholar
  89. Taberner DA, Poller L, Burslem RW, Jones JB (1978) Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. Br Med J 1:272–274PubMedCrossRefGoogle Scholar
  90. Turpie AGG, Levine MN, Hirsh J et al. (1987) A double-blind randomized trial of ORG 10172 low molecular weight heparinoid in the prevention of deep vein thrombosis in thrombotic stroke. Lancet 1:523–526PubMedCrossRefGoogle Scholar
  91. Turpie AGG, Levine MN, Powers PJ et al. (1991) A double-blind randomized trial of ORG 10172 low molecular weight heparinoid versus unfractionated heparin in the prevention of deep vein thrombosis in patients with thrombotic stroke. Thromb Haemost 65:753–761Google Scholar
  92. Venous Thrombosis Study Group (1975) Small doses of subcutaneous sodium heparin in the prevention of deep vein thrombosis after elective hip operation. Br J Surg 62:348–352CrossRefGoogle Scholar
  93. Warlow C, Ogston D, Douglas AS (1972) Venous thrombosis following strokes. Lancet 1:1305–1306PubMedCrossRefGoogle Scholar
  94. Warlow C, Beattie AG, Terry G et al. (1973) A double blind trial of low doses of subcutaneous heparin in the prevention of deep vein thrombosis after myocardial infarction. Lancet 11:934–936CrossRefGoogle Scholar
  95. Warlow C, Ogston D, Douglas AS (1976) Deep vein thrombosis of the legs after strokes. Br Med J 1:1178–1183PubMedCrossRefGoogle Scholar
  96. Willen J, Bergqvist D, Hallbrook T (1982) Venous insufficiency as a late complication of tibial fracture. Acta Orthop Scand 53:149–153PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • J. Harenberg
  • S. Haas
  • K. H. Breddin

There are no affiliations available

Personalised recommendations